Very late local recurrence of chromophobe renal cell carcinoma 15 years after nephrectomy: a case report
Chromophobe renal cell carcinoma (chRCC) is a rare subtype of renal cell carcinoma, accounting for approximately 5% of cases. Although generally associated with a favorable prognosis, late recurrences may occur. Local recurrence more than a decade after nephrectomy is exceptionally rare, and optimal management remains poorly defined. We report a 79-year-old Greek man who underwent radical left nephrectomy and adrenalectomy in 2009 for a 13 × 10 × 9 cm moderately differentiated chRCC, classified in the original pathology report as pT2 pNX pMX, G2, R0. Fifteen years later, he presented with progressive limitation of left hip flexion and increasing constipation. Contrast-enhanced CT demonstrated a solitary 9 × 8 × 7.5 cm left para-aortic retroperitoneal mass without radiologically detectable distant metastatic disease. Biopsy findings were consistent with recurrent renal cell carcinoma. The lesion was clinically classified as a local recurrence based on its location within the previous nephrectomy operative field and the absence of other metastatic lesions, although a solitary metastasis could not be unequivocally excluded histopathologically. After multidisciplinary assessment, complete surgical resection with systematic retroperitoneal lymph-node dissection was performed. Histopathological examination showed morphological features compatible with recurrence or metastasis of the previous chRCC, tumor-free margins, tumor-free sampled peritumoral skeletal muscle, and 0/16 involved lymph nodes. Immunohistochemical analysis was not performed. At 1-year follow-up, the patient remained clinically well with no radiological evidence of local recurrence or distant metastatic disease. Very late recurrence of chRCC may occur after a prolonged disease-free interval. In carefully selected patients with isolated and potentially resectable recurrence, complete surgical resection may represent a feasible treatment option within an individualized multidisciplinary approach. The 1-year follow-up in this case is insufficient to establish long-term oncological control, and continued surveillance is warranted.
Authors
- Georgios Hatzichristodoulou (ORCID: https://orcid.org/0000-0002-3170-7362)
- Anastasios Saklis
Institutions
- Martha-Maria Hospital (DE)
Publication Details
- Journal
- Journal of Medical Case Reports
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s13256-026-06881-4
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00